APO Research
Talk to an analyst

APO RESEARCH · REPORT

Custom Peptide CDMO Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Custom Peptide CDMO Services Market Outlook and Growth Opportunities 2026

3 May 2026195 pages

Choose your research edition.

Industry ResearchCustom Peptide CDMO Services Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Custom Peptide CDMO Services Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Custom Peptide CDMO Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Custom Peptide CDMO Services Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Custom Peptide CDMO Services Market Analysis and Forecast 2026-2032185 pages · $4,950 USD

Market perspective

The global Custom Peptide CDMO Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Custom Peptide CDMO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Custom Peptide CDMO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Custom Peptide CDMO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Custom Peptide CDMO Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Custom Peptide CDMO Services market include Bachem, CordenPharma, PolyPeptide, AmbioPharm, Genscript, Thermo Fisher, USV Peptides, Bio Basic and ScinoPharm, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Custom Peptide CDMO Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Custom Peptide CDMO Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Custom Peptide CDMO Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Custom Peptide CDMO Services market.

Custom Peptide CDMO Services Segment by Company

Bachem

CordenPharma

PolyPeptide

AmbioPharm

Genscript

Thermo Fisher

USV Peptides

Bio Basic

ScinoPharm

JPT

CBL

Piramal Pharma

CPC Scientific

Creative Peptides

Chinese Peptide Company

ChengDu ShengNuo Biotec

AppTec Co., Ltd.

GL Biochem

Custom Peptide CDMO Services Segment by Type

GMP Services

Non-GMP Services

Custom Peptide CDMO Services Segment by Application

Commercial

Scientific Research

Other

Custom Peptide CDMO Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Custom Peptide CDMO Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Custom Peptide CDMO Services key companies, revenue, market share, and recent developments.

3. To split the Custom Peptide CDMO Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Custom Peptide CDMO Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Custom Peptide CDMO Services significant trends, drivers, influence factors in global and regions.

6. To analyze Custom Peptide CDMO Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Peptide CDMO Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Custom Peptide CDMO Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Peptide CDMO Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Custom Peptide CDMO Services industry.

Chapter 3: Detailed analysis of Custom Peptide CDMO Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Custom Peptide CDMO Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Custom Peptide CDMO Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Custom Peptide CDMO Services Industry Trends Table 2. Custom Peptide CDMO Services Industry Drivers Table 3. Custom Peptide CDMO Services Industry Opportunities and Challenges Table 4. Custom Peptide CDMO Services Industry Restraints Table 5. Global Custom Peptide CDMO Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Custom Peptide CDMO Services Revenue Share by Company (2021-2026) Table 7. Global Custom Peptide CDMO Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Custom Peptide CDMO Services Key Company Manufacturing Base & Headquarters Table 9. Global Custom Peptide CDMO Services Company, Product Type & Application Table 10. Global Custom Peptide CDMO Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Custom Peptide CDMO Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of GMP Services Table 15. Significant Companies of Non-GMP Services Table 16. Global Custom Peptide CDMO Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Custom Peptide CDMO Services Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Custom Peptide CDMO Services Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Custom Peptide CDMO Services Sales Value Share by Type (2021-2026) Table 20. Global Custom Peptide CDMO Services Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Commercial Table 22. Significant Companies of Scientific Research Table 23. Significant Companies of Other Table 24. Global Custom Peptide CDMO Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Custom Peptide CDMO Services Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Custom Peptide CDMO Services Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Custom Peptide CDMO Services Sales Value Share by Application (2021-2026) Table 28. Global Custom Peptide CDMO Services Sales Value Share by Application (2027-2032) Table 29. Global Custom Peptide CDMO Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Custom Peptide CDMO Services Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Custom Peptide CDMO Services Sales Value Share by Region (2021-2026) Table 32. Global Custom Peptide CDMO Services Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Custom Peptide CDMO Services Sales Value Share by Region (2027-2032) Table 34. Global Custom Peptide CDMO Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Custom Peptide CDMO Services Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Custom Peptide CDMO Services Sales Value Market Share by Country (2021-2026) Table 37. Global Custom Peptide CDMO Services Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Custom Peptide CDMO Services Sales Value Market Share by Country (2027-2032) Table 39. Bachem Company Information Table 40. Bachem Business Overview Table 41. Bachem Custom Peptide CDMO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Bachem Custom Peptide CDMO Services Product Portfolio Table 43. Bachem Recent Development Table 44. CordenPharma Company Information Table 45. CordenPharma Business Overview Table 46. CordenPharma Custom Peptide CDMO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. CordenPharma Custom Peptide CDMO Services Product Portfolio Table 48. CordenPharma Recent Development Table 49. PolyPeptide Company Information Table 50. PolyPeptide Business Overview Table 51. PolyPeptide Custom Peptide CDMO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. PolyPeptide Custom Peptide CDMO Services Product Portfolio Table 53. PolyPeptide Recent Development Table 54. AmbioPharm Company Information Table 55. AmbioPharm Business Overview Table 56. AmbioPharm Custom Peptide CDMO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. AmbioPharm Custom Peptide CDMO Services Product Portfolio Table 58. AmbioPharm Recent Development Table 59. Genscript Company Information Table 60. Genscript Business Overview Table 61. Genscript Custom Peptide CDMO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Genscript Custom Peptide CDMO Services Product Portfolio Table 63. Genscript Recent Development Table 64. Thermo Fisher Company Information Table 65. Thermo Fisher Business Overview Table 66. Thermo Fisher Custom Peptide CDMO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Thermo Fisher Custom Peptide CDMO Services Product Portfolio Table 68. Thermo Fisher Recent Development Table 69. USV Peptides Company Information Table 70. USV Peptides Business Overview Table 71. USV Peptides Custom Peptide CDMO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. USV Peptides Custom Peptide CDMO Services Product Portfolio Table 73. USV Peptides Recent Development Table 74. Bio Basic Company Information Table 75. Bio Basic Business Overview Table 76. Bio Basic Custom Peptide CDMO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Bio Basic Custom Peptide CDMO Services Product Portfolio Table 78. Bio Basic Recent Development Table 79. ScinoPharm Company Information Table 80. ScinoPharm Business Overview Table 81. ScinoPharm Custom Peptide CDMO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. ScinoPharm Custom Peptide CDMO Services Product Portfolio Table 83. ScinoPharm Recent Development Table 84. JPT Company Information Table 85. JPT Business Overview Table 86. JPT Custom Peptide CDMO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. JPT Custom Peptide CDMO Services Product Portfolio Table 88. JPT Recent Development Table 89. CBL Company Information Table 90. CBL Business Overview Table 91. CBL Custom Peptide CDMO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. CBL Custom Peptide CDMO Services Product Portfolio Table 93. CBL Recent Development Table 94. Piramal Pharma Company Information Table 95. Piramal Pharma Business Overview Table 96. Piramal Pharma Custom Peptide CDMO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Piramal Pharma Custom Peptide CDMO Services Product Portfolio Table 98. Piramal Pharma Recent Development Table 99. CPC Scientific Company Information Table 100. CPC Scientific Business Overview Table 101. CPC Scientific Custom Peptide CDMO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. CPC Scientific Custom Peptide CDMO Services Product Portfolio Table 103. CPC Scientific Recent Development Table 104. Creative Peptides Company Information Table 105. Creative Peptides Business Overview Table 106. Creative Peptides Custom Peptide CDMO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Creative Peptides Custom Peptide CDMO Services Product Portfolio Table 108. Creative Peptides Recent Development Table 109. Chinese Peptide Company Company Information Table 110. Chinese Peptide Company Business Overview Table 111. Chinese Peptide Company Custom Peptide CDMO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Chinese Peptide Company Custom Peptide CDMO Services Product Portfolio Table 113. Chinese Peptide Company Recent Development Table 114. ChengDu ShengNuo Biotec Company Information Table 115. ChengDu ShengNuo Biotec Business Overview Table 116. ChengDu ShengNuo Biotec Custom Peptide CDMO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. ChengDu ShengNuo Biotec Custom Peptide CDMO Services Product Portfolio Table 118. ChengDu ShengNuo Biotec Recent Development Table 119. AppTec Co., Ltd. Company Information Table 120. AppTec Co., Ltd. Business Overview Table 121. AppTec Co., Ltd. Custom Peptide CDMO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. AppTec Co., Ltd. Custom Peptide CDMO Services Product Portfolio Table 123. AppTec Co., Ltd. Recent Development Table 124. GL Biochem Company Information Table 125. GL Biochem Business Overview Table 126. GL Biochem Custom Peptide CDMO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. GL Biochem Custom Peptide CDMO Services Product Portfolio Table 128. GL Biochem Recent Development Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Custom Peptide CDMO Services Product Image Figure 2. Global Custom Peptide CDMO Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Custom Peptide CDMO Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Custom Peptide CDMO Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. GMP Services Image Figure 8. Non-GMP Services Image Figure 9. Global Custom Peptide CDMO Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Custom Peptide CDMO Services Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Custom Peptide CDMO Services Sales Value Share by Type (2021-2032) Figure 12. Commercial Image Figure 13. Scientific Research Image Figure 14. Other Image Figure 15. Global Custom Peptide CDMO Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Custom Peptide CDMO Services Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Custom Peptide CDMO Services Sales Value Share by Application (2021-2032) Figure 18. Global Custom Peptide CDMO Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Custom Peptide CDMO Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Custom Peptide CDMO Services Sales Value (2021-2032) & (US$ Million) Figure 21. North America Custom Peptide CDMO Services Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Custom Peptide CDMO Services Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Custom Peptide CDMO Services Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Custom Peptide CDMO Services Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Custom Peptide CDMO Services Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Custom Peptide CDMO Services Sales Value (2021-2032) & (US$ Million) Figure 27. South America Custom Peptide CDMO Services Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Custom Peptide CDMO Services Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Custom Peptide CDMO Services Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • GMP Services
  • Non-GMP Services
Applications
  • Commercial
  • Scientific Research
  • Other
Companies covered
  • Bachem
  • CordenPharma
  • PolyPeptide
  • AmbioPharm
  • Genscript
  • Thermo Fisher
  • USV Peptides
  • Bio Basic
  • ScinoPharm
  • JPT
  • CBL
  • Piramal Pharma
  • CPC Scientific
  • Creative Peptides
  • Chinese Peptide Company
  • ChengDu ShengNuo Biotec
  • AppTec Co., Ltd.
  • GL Biochem

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Custom Peptide CDMO Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Custom Peptide CDMO Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Custom Peptide CDMO Services Market Dynamics
  1. 2.1 Custom Peptide CDMO Services Industry Trends
  2. 2.2 Custom Peptide CDMO Services Industry Drivers
  3. 2.3 Custom Peptide CDMO Services Industry Opportunities and Challenges
  4. 2.4 Custom Peptide CDMO Services Industry Restraints
3 Custom Peptide CDMO Services Market by Company
  1. 3.1 Global Custom Peptide CDMO Services Company Revenue Ranking in 2025
  2. 3.2 Global Custom Peptide CDMO Services Revenue by Company (2021-2026)
  3. 3.3 Global Custom Peptide CDMO Services Company Ranking (2024-2026)
  4. 3.4 Global Custom Peptide CDMO Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Custom Peptide CDMO Services Company Product Type and Application
  6. 3.6 Global Custom Peptide CDMO Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Custom Peptide CDMO Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Custom Peptide CDMO Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Custom Peptide CDMO Services Market by Type
  1. 4.1 Custom Peptide CDMO Services Type Introduction
  2. 4.1.1 GMP Services
  3. 4.1.2 Non-GMP Services
  4. 4.2 Global Custom Peptide CDMO Services Sales Value by Type
  5. 4.2.1 Global Custom Peptide CDMO Services Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Custom Peptide CDMO Services Sales Value by Type (2021-2032)
  7. 4.2.3 Global Custom Peptide CDMO Services Sales Value Share by Type (2021-2032)
5 Custom Peptide CDMO Services Market by Application
  1. 5.1 Custom Peptide CDMO Services Application Introduction
  2. 5.1.1 Commercial
  3. 5.1.2 Scientific Research
  4. 5.1.3 Other
  5. 5.2 Global Custom Peptide CDMO Services Sales Value by Application
  6. 5.2.1 Global Custom Peptide CDMO Services Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Custom Peptide CDMO Services Sales Value by Application (2021-2032)
  8. 5.2.3 Global Custom Peptide CDMO Services Sales Value Share by Application (2021-2032)
6 Custom Peptide CDMO Services Regional Value Analysis
  1. 6.1 Global Custom Peptide CDMO Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Custom Peptide CDMO Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Custom Peptide CDMO Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Custom Peptide CDMO Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Custom Peptide CDMO Services Sales Value (2021-2032)
  7. 6.3.2 North America Custom Peptide CDMO Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Custom Peptide CDMO Services Sales Value (2021-2032)
  10. 6.4.2 Europe Custom Peptide CDMO Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Custom Peptide CDMO Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Custom Peptide CDMO Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Custom Peptide CDMO Services Sales Value (2021-2032)
  16. 6.6.2 South America Custom Peptide CDMO Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Custom Peptide CDMO Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Custom Peptide CDMO Services Sales Value Share by Country, 2025 VS 2032
7 Custom Peptide CDMO Services Country-level Value Analysis
  1. 7.1 Global Custom Peptide CDMO Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Custom Peptide CDMO Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Custom Peptide CDMO Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Custom Peptide CDMO Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Custom Peptide CDMO Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Custom Peptide CDMO Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Custom Peptide CDMO Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bachem
  2. 8.1.1 Bachem Company Information
  3. 8.1.2 Bachem Business Overview
  4. 8.1.3 Bachem Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bachem Custom Peptide CDMO Services Product Portfolio
  6. 8.1.5 Bachem Recent Developments
  7. 8.2 CordenPharma
  8. 8.2.1 CordenPharma Company Information
  9. 8.2.2 CordenPharma Business Overview
  10. 8.2.3 CordenPharma Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CordenPharma Custom Peptide CDMO Services Product Portfolio
  12. 8.2.5 CordenPharma Recent Developments
  13. 8.3 PolyPeptide
  14. 8.3.1 PolyPeptide Company Information
  15. 8.3.2 PolyPeptide Business Overview
  16. 8.3.3 PolyPeptide Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 PolyPeptide Custom Peptide CDMO Services Product Portfolio
  18. 8.3.5 PolyPeptide Recent Developments
  19. 8.4 AmbioPharm
  20. 8.4.1 AmbioPharm Company Information
  21. 8.4.2 AmbioPharm Business Overview
  22. 8.4.3 AmbioPharm Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AmbioPharm Custom Peptide CDMO Services Product Portfolio
  24. 8.4.5 AmbioPharm Recent Developments
  25. 8.5 Genscript
  26. 8.5.1 Genscript Company Information
  27. 8.5.2 Genscript Business Overview
  28. 8.5.3 Genscript Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Genscript Custom Peptide CDMO Services Product Portfolio
  30. 8.5.5 Genscript Recent Developments
  31. 8.6 Thermo Fisher
  32. 8.6.1 Thermo Fisher Company Information
  33. 8.6.2 Thermo Fisher Business Overview
  34. 8.6.3 Thermo Fisher Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Thermo Fisher Custom Peptide CDMO Services Product Portfolio
  36. 8.6.5 Thermo Fisher Recent Developments
  37. 8.7 USV Peptides
  38. 8.7.1 USV Peptides Company Information
  39. 8.7.2 USV Peptides Business Overview
  40. 8.7.3 USV Peptides Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 USV Peptides Custom Peptide CDMO Services Product Portfolio
  42. 8.7.5 USV Peptides Recent Developments
  43. 8.8 Bio Basic
  44. 8.8.1 Bio Basic Company Information
  45. 8.8.2 Bio Basic Business Overview
  46. 8.8.3 Bio Basic Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bio Basic Custom Peptide CDMO Services Product Portfolio
  48. 8.8.5 Bio Basic Recent Developments
  49. 8.9 ScinoPharm
  50. 8.9.1 ScinoPharm Company Information
  51. 8.9.2 ScinoPharm Business Overview
  52. 8.9.3 ScinoPharm Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 ScinoPharm Custom Peptide CDMO Services Product Portfolio
  54. 8.9.5 ScinoPharm Recent Developments
  55. 8.10 JPT
  56. 8.10.1 JPT Company Information
  57. 8.10.2 JPT Business Overview
  58. 8.10.3 JPT Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 JPT Custom Peptide CDMO Services Product Portfolio
  60. 8.10.5 JPT Recent Developments
  61. 8.11 CBL
  62. 8.11.1 CBL Company Information
  63. 8.11.2 CBL Business Overview
  64. 8.11.3 CBL Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 CBL Custom Peptide CDMO Services Product Portfolio
  66. 8.11.5 CBL Recent Developments
  67. 8.12 Piramal Pharma
  68. 8.12.1 Piramal Pharma Company Information
  69. 8.12.2 Piramal Pharma Business Overview
  70. 8.12.3 Piramal Pharma Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Piramal Pharma Custom Peptide CDMO Services Product Portfolio
  72. 8.12.5 Piramal Pharma Recent Developments
  73. 8.13 CPC Scientific
  74. 8.13.1 CPC Scientific Company Information
  75. 8.13.2 CPC Scientific Business Overview
  76. 8.13.3 CPC Scientific Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 CPC Scientific Custom Peptide CDMO Services Product Portfolio
  78. 8.13.5 CPC Scientific Recent Developments
  79. 8.14 Creative Peptides
  80. 8.14.1 Creative Peptides Company Information
  81. 8.14.2 Creative Peptides Business Overview
  82. 8.14.3 Creative Peptides Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Creative Peptides Custom Peptide CDMO Services Product Portfolio
  84. 8.14.5 Creative Peptides Recent Developments
  85. 8.15 Chinese Peptide Company
  86. 8.15.1 Chinese Peptide Company Company Information
  87. 8.15.2 Chinese Peptide Company Business Overview
  88. 8.15.3 Chinese Peptide Company Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Chinese Peptide Company Custom Peptide CDMO Services Product Portfolio
  90. 8.15.5 Chinese Peptide Company Recent Developments
  91. 8.16 ChengDu ShengNuo Biotec
  92. 8.16.1 ChengDu ShengNuo Biotec Company Information
  93. 8.16.2 ChengDu ShengNuo Biotec Business Overview
  94. 8.16.3 ChengDu ShengNuo Biotec Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 ChengDu ShengNuo Biotec Custom Peptide CDMO Services Product Portfolio
  96. 8.16.5 ChengDu ShengNuo Biotec Recent Developments
  97. 8.17 AppTec Co., Ltd.
  98. 8.17.1 AppTec Co., Ltd. Company Information
  99. 8.17.2 AppTec Co., Ltd. Business Overview
  100. 8.17.3 AppTec Co., Ltd. Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  101. 8.17.4 AppTec Co., Ltd. Custom Peptide CDMO Services Product Portfolio
  102. 8.17.5 AppTec Co., Ltd. Recent Developments
  103. 8.18 GL Biochem
  104. 8.18.1 GL Biochem Company Information
  105. 8.18.2 GL Biochem Business Overview
  106. 8.18.3 GL Biochem Custom Peptide CDMO Services Revenue and Gross Margin (2021-2026)
  107. 8.18.4 GL Biochem Custom Peptide CDMO Services Product Portfolio
  108. 8.18.5 GL Biochem Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst